Evidence map›Paper›PMID 38369807›Full record

ArticleESC heart failure2024

Distinct myocardial triglyceride lipolysis pathways in primary and idiopathic triglyceride deposit cardiomyovasculopathy.

Yoshihiko Ikeda, Mikio Shiba, Hiroyuki Yamamoto, Tomonori Itoh, Takahiro Okumura, Yusuke Nakano, Hideyuki Miyauchi, Tomomi Ide, Sohsuke Yamada, Hiroyuki Hao and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yoshihiko IkedaDepartment of Pathology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Mikio ShibaCardiovascular Division, Osaka Police Hospital, Osaka, Japan.
Hiroyuki YamamotoDepartment of Cardiovascular Medicine, Narita-Tomisato Tokushukai Hospital, Chiba, Japan.
Tomonori ItohDepartment of Internal Medicine, Division of Cardiology, Iwate Medical University, Iwate, Japan.
Takahiro OkumuraDepartment of Cardiology, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
Yusuke NakanoDepartment of Cardiology, Aichi Medical University, Nagakute, Japan.
Hideyuki MiyauchiDepartment of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
Tomomi IdeDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Sohsuke YamadaDepartment of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada, Japan.
Hiroyuki HaoDepartment of Pathology and Microbiology, Division of Human Pathology, Nihon University School of Medicine, Tokyo, Japan.
Seiya KatoDivision of Pathology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
Ken-Ichi HiranoDepartment of Triglyceride Science, Graduate School of Medicine, Osaka University, Osaka, Japan.
Japan TGCV study group

Funding

Japan Agency of Medical Research and Development (A-MED) 22ek0109479h0003Ministry of Health, Labour, and Welfare of Japan
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LipolysisMyocardiumHumansMutationTriglyceridesTriglycerides

Identifiers

PMID38369807
PMCPMC10966204

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.